Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
152500 ETF · KINDEX Leverage ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | +40.91% | +62.16% | +653.31% | +599.19% | +307.44% | +64.02% | +64.02% | +129.00% | |
| Flows |
Key fund info
Essentials
Enterprise
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +62.16% | +653.31% | +599.19% | +307.44% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
The 152500 ETF provides synthetic exposure. It uses derivatives to replicate the index's performance, so we do not display its exposure breakdown.
To find out more about 152500's exposure, please refer to the as provided by Korea Investment Management.
Sustainability
Replication
Issuer
| AuM | ||
|---|---|---|
105190 | KINDEX 200 ETF | €894M |
245710 | KINDEX Vietnam VN30 (Synth) ETF | €189M |
168580 | KINDEX China CSI300 ETF | €73M |
108450 | KINDEX Samsung Group SW ETF | €57M |
272910 | KIM KINDEX ACTIVE KOREA TREASURY&AGENCY BONDS ETF | €49M |
Frequently asked questions about 152500
What does KINDEX Leverage ETF, 152500, invest in?
152500 is a Passive ETF. This ETF provides leveraged exposure (2x) to Large Cap South Korean Equities.
Which benchmark or index does 152500 replicate?
152500 tracks the KOSPI200 Leverage Index - KRW, through a unfunded swap replication method.
What is the Total Expense ratio (TER) of 152500?
152500 carries a total expense ratio (TER) of 0.3%, indicating the annual cost for holding the fund.
When was 152500 launched?
152500 was introduced to the market on January 27, 2012. It trades on Congo, The Democratic Republic of the, among other exchanges
Who is the ETF issuer of 152500?
KINDEX Leverage ETF, 152500, is provided by Korea Investment Management. Learn more about Korea Investment Management here.
What is the current assets under management (AUM) of 152500?
152500 oversees €36M in assets as of April 22, 2026.
How has 152500 performed lately?
Based on data from April 22, 2026, 152500 returned 40.91% over the past month, 62.16% over the last three months and 129.00% year-to-date.
What are the latest inflows or outflows for 152500?
As of April 22, 2026, 152500 recorded net flows of +€1.7M over the last month and +€3.4M year-to-date.
Does 152500 distribute dividends?
152500 follows a capitalizing, meaning it reinvests income within the fund. As of April 22, 2026, its 12-month trailing yield was 0.53%.
What is the base currency of 152500?
The base currency of 152500 is KRW.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
